EMA recommends suspension of sickle cell disease medicine Oxbryta
EMA recommends suspension of sickle cell disease medicine Oxbryta
EMA recommends suspension of sickle cell disease medicine Oxbryta
New fee regulation: webinar for veterinary industry stakeholders, Online, 24 October 2024
MedDRA important medical event terms list - version 27.1
Agenda - ACT EU multi-stakeholder platform annual meeting
Agenda of the Extraordinary CHMP meeting 26 September 2024
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 26 September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 September 2024, 10:00 (CEST) to 26 September 2024, 13:00 (CEST)
Superseded community herbal monograph on Rosmarinus officinalis L., folium
List of centrally authorised products with safety-related changes to the product information
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Status: Authorised
List of eligible industry stakeholder organisations